These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 43163

  • 1. Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.
    Sanders GL, Murray A, Rawlins MD.
    Br J Clin Pharmacol; 1979; 8(Suppl 2):125S-127S. PubMed ID: 43163
    [Abstract] [Full Text] [Related]

  • 2. Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.
    Sanders GL, Murray A, Rawlins MD.
    Br J Clin Pharmacol; 1979 Apr; 8 Suppl 2():125S-7S. PubMed ID: 26635152
    [Abstract] [Full Text] [Related]

  • 3. The effect of exercise on intra-arterial blood pressure and pulse rate before and during long-term high-dose treatment with labetalol in patients with severe, therapy-resistant hypertension.
    la Cour Petersen E, Kristensen BO.
    Postgrad Med J; 1980 Apr; 56 Suppl 2():60-4. PubMed ID: 7433345
    [Abstract] [Full Text] [Related]

  • 4. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
    Martinand A, Lardoux H, Corvol P, Milliez P.
    Nouv Presse Med; 1980 Sep 27; 9(35):2565-8. PubMed ID: 7001349
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Hypotensive effect and changes of arterial pressure variability induced by treatment with labetalol in patients with slight and moderate arterial hypertension].
    Palatini P, Pessina AC, Sperti G, Ventura E, Agnoletto V, Semplicini A, Hlede M, Gava R, Mormino P, Dal Palù C.
    G Ital Cardiol; 1983 Sep 27; 13(1):18-22. PubMed ID: 6873535
    [Abstract] [Full Text] [Related]

  • 7. Effect of labetalol on continuous ambulatory blood pressure.
    Balasubramanian V, Mann S, Raftery EB, Millar-Craig MW, Altman D.
    Br J Clin Pharmacol; 1979 Sep 27; 8(Suppl 2):119S-123S. PubMed ID: 526391
    [Abstract] [Full Text] [Related]

  • 8. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
    Sassard J, Zech PY, Pozet N, Cuisinaud G, Vincent M.
    J Pharmacol; 1983 Sep 27; 14 Suppl 2():121-9. PubMed ID: 6355664
    [Abstract] [Full Text] [Related]

  • 9. Acute management of severe hypertension with oral labetalol.
    Ghose RR.
    Br J Clin Pharmacol; 1979 Sep 27; 8(Suppl 2):189S-193S. PubMed ID: 526400
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics, beta-adrenoceptor blockade and anti-hypertensive action of labetalol during chronic oral treatment.
    Sanders GL, Davies DM, Rawlins MD.
    Br J Clin Pharmacol; 1980 Aug 27; 10(2):121-6. PubMed ID: 6252915
    [Abstract] [Full Text] [Related]

  • 13. Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine.
    Lehtonen A, Allonen H, Kleimola T.
    Int J Clin Pharmacol Biopharm; 1979 Feb 27; 17(2):71-5. PubMed ID: 422304
    [Abstract] [Full Text] [Related]

  • 14. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension.
    Ronne-Rasmussen JO, Andersen GS, Jensen NB, Andersson E.
    Br J Clin Pharmacol; 1976 Aug 27; 3(4 Suppl 3):805-8. PubMed ID: 990157
    [Abstract] [Full Text] [Related]

  • 15. A comparison and an investigation of a potential synergistic effect of labetalol and bethanidine in patients with mild hypertension.
    Chalmers AG, Hunter J, Lees CD, Millar JA, Brown JJ, Robertson JI.
    Br J Clin Pharmacol; 1979 Aug 27; 8(Suppl 2):183S-187S. PubMed ID: 526399
    [Abstract] [Full Text] [Related]

  • 16. Haemodynamic effects of long-term oral labetalol.
    Edwards RC, Raftery EB.
    Br J Clin Pharmacol; 1976 Aug 27; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [Abstract] [Full Text] [Related]

  • 17. Labetalol in resistant hypertension.
    Dargie HJ, Dollery CT, Daniel J.
    Br J Clin Pharmacol; 1976 Aug 27; 3(4 Suppl 3):751-5. PubMed ID: 990154
    [Abstract] [Full Text] [Related]

  • 18. Effect of labetalol on plasma catecholamines at rest and during increased sympathetic activity.
    Carlsen JE, Trap-Jensen J, Svendsen TL, Nielsen PE, Rasmussen S, Christensen NJ.
    Postgrad Med J; 1980 Aug 27; 56 Suppl 2():43-8. PubMed ID: 7433342
    [Abstract] [Full Text] [Related]

  • 19. Blood pressure, plasma volume, extracellular volume and glomerular filtration rate during treatment with labetalol in essential hypertension.
    Rasmussen S, Nielsen PE.
    Postgrad Med J; 1980 Aug 27; 56 Suppl 2():33-6. PubMed ID: 7433340
    [Abstract] [Full Text] [Related]

  • 20. Double-blind trial of labetalol.
    Kane J, Gregg I, Richards DA.
    Br J Clin Pharmacol; 1976 Aug 27; 3(4 Suppl 3):737-41. PubMed ID: 791329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.